Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Horowitz

Showing results (561-570 of 598) with videos related to

Pageof 60
Sort By:
The New England Journal of Medicine|October 23, 2018
Energy-Dense versus Routine Enteral Nutrition in the Critically Ill, Marianne Chapman, Sandra L Peake, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2020
Acceleration of Gastric Emptying by Insulin-Induced Hypoglycemia is Dependent on the Degree of HypoglycemiaTejaswini Arunachala Murthy, Jacqueline Grivell, Seva Hatzinikolas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
Neurosurgery|November 26, 2010
In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial aneurysmsHilal Kanaan, Brian Jankowitz, Aitziber Aleu, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 11, 2006
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposedTanya J Little, Selena Doran, James H Meyer, et al.
Diabetes|October 4, 2013
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemiaMahesh M Umapathysivam, Michael Y Lee, Karen L Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2009
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemiaAdam M Deane, Nam Q Nguyen, Julie E Stevens, et al.
Diabetes|October 17, 2015
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled TrialSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes Care|November 10, 2020
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821Christopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Diabetes Care|May 31, 2020
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled TrialChristopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Pageof 60

Showing results (561-570 of 598) with videos related to

Sort By:
Pageof 60
The New England Journal of Medicine|October 23, 2018
Energy-Dense versus Routine Enteral Nutrition in the Critically Ill, Marianne Chapman, Sandra L Peake, et al.
The Journal of Clinical Endocrinology and Metabolism|November 24, 2020
Acceleration of Gastric Emptying by Insulin-Induced Hypoglycemia is Dependent on the Degree of HypoglycemiaTejaswini Arunachala Murthy, Jacqueline Grivell, Seva Hatzinikolas, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|April 23, 2022
Acute Administration of the GLP-1 Receptor Agonist Lixisenatide Diminishes Postprandial Insulin Secretion in Healthy Subjects But Not in Type 2 Diabetes, Associated with Slowing of Gastric EmptyingChinmay S Marathe, Hung Pham, Tongzhi Wu, et al.
Neurosurgery|November 26, 2010
In-stent thrombosis and stenosis after neck-remodeling device-assisted coil embolization of intracranial aneurysmsHilal Kanaan, Brian Jankowitz, Aitziber Aleu, et al.
American Journal of Physiology. Endocrinology and Metabolism|May 11, 2006
The release of GLP-1 and ghrelin, but not GIP and CCK, by glucose is dependent upon the length of small intestine exposedTanya J Little, Selena Doran, James H Meyer, et al.
Diabetes|October 4, 2013
Comparative effects of prolonged and intermittent stimulation of the glucagon-like peptide 1 receptor on gastric emptying and glycemiaMahesh M Umapathysivam, Michael Y Lee, Karen L Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|November 7, 2009
Endogenous glucagon-like peptide-1 slows gastric emptying in healthy subjects, attenuating postprandial glycemiaAdam M Deane, Nam Q Nguyen, Julie E Stevens, et al.
Diabetes|October 17, 2015
The Glucagon-Like Peptide 1 Receptor Agonist Exenatide Inhibits Small Intestinal Motility, Flow, Transit, and Absorption of Glucose in Healthy Subjects and Patients With Type 2 Diabetes: A Randomized Controlled TrialSony S Thazhath, Chinmay S Marathe, Tongzhi Wu, et al.
Diabetes Care|November 10, 2020
Erratum. Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled Trial. Diabetes Care 2020;43:1813-1821Christopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Diabetes Care|May 31, 2020
Effects of Sustained Treatment With Lixisenatide on Gastric Emptying and Postprandial Glucose Metabolism in Type 2 Diabetes: A Randomized Controlled TrialChristopher K Rayner, Linda E Watson, Liza K Phillips, et al.
Pageof 60